Cheng, Elvin S. http://orcid.org/0000-0003-0021-196X
Weber, Marianne F. http://orcid.org/0000-0001-5731-9651
Steinberg, Julia http://orcid.org/0000-0002-0585-2312
Canfell, Karen http://orcid.org/0000-0002-6443-6618
Yu, Xue Qin http://orcid.org/0000-0001-8638-7979
Funding for this research was provided by:
University of Sydney
Article History
Received: 19 July 2021
Accepted: 26 April 2022
First Online: 27 May 2022
Declarations
:
: KC is co-principal investigator of an investigator-initiated trial of cytology and primary HPV screening in Australia (Compass; ACTRN12613001207707 and NCT02328872), which is conducted and funded by the VCS Foundation, a government-funded health promotion charity. The VCS Foundation received equipment and a funding contribution for the Compass trial from Roche Molecular Systems and Ventana USA. However, neither KC nor her institution on her behalf (Cancer Council NSW) has received direct or indirect funding from industry for Compass or any other project. All authors declare that they have no conflicts of interest.
: This analysis was covered by ethics approval from the NSW Population and Health Services Research Ethics Committee (HREC/14/CIPHS/54) for the 45 and Up Study data and (HREC/14/CIPHS/36) for the CLEAR Study data. All procedures were performed in accordance with the principles laid down in the Declaration of Helsinki; and the recommendations guiding physicians in biomedical research involving human subjects.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.